RSSMicro.com Search - RSS Feed Search Engine - RSS Feed Directory
Dedicated RSS Feed Search Engine
 Search 4.3 million RSS feeds
The most comprehensive RSS feed search on the web
Top Stories  |  FeedRank Checker

Published

   Last Hour

   Last Day

   Past Week

   Past Month

 Anytime







Featured
RSS Feeds


CNN RSS Feeds

Reuters RSS Feeds

MSNBC RSS Feeds

New York Times RSS Feeds

Washington Post RSS Feeds

CNBC RSS Feeds

ABC News RSS Feeds

Fox News RSS Feeds

Sky News RSS Feeds

Forbes RSS Feeds

CNET RSS Feeds

Unicef RSS Feeds

PBS RSS Feeds

Wall Street Journal RSS Feeds

Financial Times RSS Feeds

Business Week RSS Feeds

Bloomberg RSS Feeds

TheStreet RSS Feeds

ESPN RSS Feeds

   




FeedRank - RSSMicro Search

FeedRank, a newly developed algorithm for ranking RSS feeds only on RSSMicro
Click here to learn more


NCBI PubMed


FeedRank: 8/10  8/10  Excellent  ---  eutils.ncbi.nlm.nih.gov
NCBI: db=PubMed; Term=embryonic stem cells ...

 

 



Saturday, July 12, 2008 --- 145 days ago
Related Articles Cell therapies: realizing the potential of this new dimension to medical therapeutics. J Tissue Eng Regen Med. 2008 Jul 10; Authors: Singh P, Williams DJ Stem cells promise to treat conditions poorly served by conventional therapeutics. Cells from both embryonic and somatic tissues are being used to create cell therapies for genetic, traumatic and degenerative conditions. The current human, healthcare and fiscal costs of these conditions are significant. This review summarizes the use of stem cells for neurological and cardiac disorders and diabetes to determine the requirements for generic translational research to assist such therapies to be a reality. While there are multiple strategies in each disease area, with no clear favourite, there are clear opportunities in treatments that use a single cell type. A key requirement is to work with pluripotent progenitor cells to cultivate and differentiate a sufficiently large population of functioning cells. Challenges also arise in determining and achieving timely delivery of the correct dose of cells to where they can most effectively treat the disease and best benefit individual patients. Copyright (c) 2008 John Wiley & Sons, Ltd. PMID: 18618613 [PubMed - as supplied by publisher] ...




Recent Posts





 Facebook     Del.icio.us     Digg     StumbleUpon     Reddit     Google
Copyright © 2008 RSSMicro.com